Hui-Fen Chiu Selected Research

Peripheral Vascular Diseases (Peripheral Vascular Disease)

1/2008	Does arsenic exposure increase the risk for prostate cancer?
1/2008	Is colon cancer mortality related to arsenic exposure?
5/2005	Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan.
3/2005	Decreasing trend in renal disease mortality after cessation from arsenic exposure in a previous arseniasis-endemic area in southwestern Taiwan.
12/2004	Lung cancer mortality reduction after installation of tap-water supply system in an arseniasis-endemic area in Southwestern Taiwan.
10/2004	Does arsenic exposure increase the risk for liver cancer?
9/2004	Reduction in kidney cancer mortality following installation of a tap water supply system in an arsenic-endemic area of Taiwan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Fen Chiu Research Topics

Disease

17	Neoplasms (Cancer) 05/2017 - 12/2002
7	Lung Neoplasms (Lung Cancer) 05/2017 - 12/2004
7	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2008 - 09/2004
6	Asthma (Bronchial Asthma) 10/2015 - 06/2003
5	Hypertension (High Blood Pressure) 01/2017 - 04/2007
4	Chronic Obstructive Pulmonary Disease (COPD) 10/2015 - 11/2008
4	Esophageal Neoplasms (Esophageal Cancer) 05/2013 - 12/2002
4	Urinary Bladder Neoplasms (Bladder Cancer) 09/2012 - 05/2005
4	Kidney Neoplasms (Kidney Cancer) 07/2012 - 09/2004
4	Hepatocellular Carcinoma (Hepatoma) 04/2006 - 04/2002
3	Pneumonia (Pneumonitis) 10/2015 - 11/2009
3	Cardiac Arrhythmias (Arrythmia) 01/2013 - 01/2009
3	Stomach Neoplasms (Stomach Cancer) 01/2012 - 01/2011
3	Colonic Neoplasms (Colon Cancer) 09/2011 - 01/2008
3	Pancreatic Neoplasms (Pancreatic Cancer) 07/2011 - 01/2009
3	Liver Neoplasms (Liver Cancer) 05/2011 - 12/2002
2	Myocardial Infarction 01/2017 - 07/2006
2	Headache (Headaches) 02/2015 - 01/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2012 - 03/2004
2	Colorectal Neoplasms (Colorectal Cancer) 12/2011 - 06/2005
2	Prostatic Neoplasms (Prostate Cancer) 12/2011 - 01/2008
2	Leukemia 01/2009 - 01/2008
2	Heart Failure 01/2009 - 08/2007
2	Cerebral Hemorrhage 03/2007 - 11/2003
1	Peptic Ulcer (Peptic Ulcers) 01/2019
1	Breast Neoplasms (Breast Cancer) 10/2017
1	Carcinogenesis 05/2017
1	Endometrial Neoplasms (Endometrial Cancer) 10/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2016
1	Brain Neoplasms (Brain Tumor) 04/2016
1	Allergic Rhinitis 01/2016
1	Migraine Disorders (Migraine) 01/2015
1	Human Influenza (Influenza) 04/2014
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2014
1	Cholelithiasis 05/2012
1	Adenocarcinoma of Lung 02/2012
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2009
1	Dyslipidemias (Dyslipidemia) 01/2008
1	Stroke (Strokes) 03/2007
1	Vascular Diseases (Vascular Disease) 03/2007
1	Diabetes Mellitus 01/2006
1	Glioma (Gliomas) 09/2005
1	Renal Insufficiency (Renal Failure) 12/2003
1	Ischemic Stroke 11/2003
1	Edema (Dropsy) 03/2003
1	Birth Weight (Birth Weights) 12/2002

Drug/Important Bio-Agent (IBA)

22	Drinking WaterIBA 01/2013 - 12/2002
16	Air Pollutants (Pollutants, Air)IBA 01/2019 - 07/2006
13	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019 - 11/2003
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2016 - 01/2008
12	MagnesiumIBA 01/2013 - 12/2002
10	CalciumIBA 01/2013 - 12/2002
9	ArsenicIBA 01/2008 - 09/2004
6	NitratesIBA 01/2013 - 06/2007
4	Particulate MatterIBA 02/2015 - 08/2011
3	OzoneIBA 01/2017 - 01/2015
3	Nitrogen DioxideIBA 02/2015 - 01/2008
3	TrihalomethanesIBA 01/2013 - 07/2010
3	Indicators and Reagents (Reagents)IBA 01/2011 - 01/2009
2	Diphosphonates (Bisphosphonates)IBA 10/2017 - 10/2016
2	EnzymesIBA 05/2017 - 02/2012
2	DNA (Deoxyribonucleic Acid)IBA 05/2017 - 02/2012
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 05/2017 - 02/2012
2	antineoplaston A10 (A 10)IBA 10/2015 - 01/2013
2	Sulfur DioxideIBA 02/2015 - 01/2015
2	Carbon MonoxideIBA 02/2015 - 01/2015
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2008 - 04/2007
2	AnthraquinonesIBA 09/2005 - 12/2002
2	AcetogeninsIBA 03/2003 - 04/2002
1	Etidronic Acid (HEDP)FDA LinkGeneric 10/2017
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 10/2017
1	Pharmaceutical PreparationsIBA 05/2017
1	Transcription Factors (Transcription Factor)IBA 05/2017
1	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017
1	Matrix Metalloproteinases (MMPs)IBA 05/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2016
1	ORALIT (ORS)IBA 04/2014
1	Topoisomerase II InhibitorsIBA 02/2012
1	trioctyl phosphine oxide (TOPO)IBA 02/2012
1	Antihypertensive Agents (Antihypertensives)IBA 04/2007
1	Cytostatic AgentsIBA 04/2006
1	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2006
1	1,5-diamidoanthraquinoneIBA 04/2006
1	Antineoplastic Agents (Antineoplastics)IBA 09/2005
1	UridineIBA 06/2005
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2003
1	tetrahydrofuranIBA 03/2003
1	CarrageenanIBA 03/2003
1	Leflunomide (Arava)FDA LinkGeneric 03/2003

Therapy/Procedure

3	Ambulatory Care (Outpatient Care) 01/2016 - 01/2015
1	Therapeutics 05/2017
1	Cholecystectomy 05/2012